Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2003 Aug;62(8):722–727. doi: 10.1136/ard.62.8.722

Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years

C Turesson 1, W O'Fallon 1, C Crowson 1, S Gabriel 1, E Matteson 1
PMCID: PMC1754626  PMID: 12860726

Abstract

Objective: To investigate the trends in incidence of extra-articular rheumatoid arthritis (ExRA) in a well defined community based cohort of patients with rheumatoid arthritis (RA), and to examine possible predictors of ExRA occurrence.

Methods: Using the resources of the Rochester Epidemiology Project, a retrospective medical record review was conducted of a cohort of 609 cases of RA in Olmsted County, MN, diagnosed during 1955–94. These cases had been previously classified using the ACR 1987 criteria for RA. Patients were followed up from 1955 to 2000 (median follow up 11.8 years; range 0.1–42.8), and incident ExRA manifestations were recorded according to predefined criteria. Time to first presentation of ExRA was compared in patients with RA by decade of diagnosis. Possible ExRA risk factors were identified in case record reviews.

Results: ExRA occurred in 247 patients (40.6%). A subgroup of 78 patients (12.8%) had ExRA manifestations considered to be severe in a previous study from Malmö, Sweden. The incidence of severe ExRA did not change significantly over the decades (p=0.165). In a multivariate analysis the main predictors of severe ExRA were smoking at RA diagnosis (risk ratio (RR)=2.94; 95% confidence interval (95% CI) 1.68 to 5.13) and early disability (Steinbrocker class III-IV at diagnosis) (RR=2.45; 95% CI 1.51 to 4.00). The effect of smoking overwhelmed the weaker effect of rheumatoid factor seropositivity.

Conclusion: There was no decrease in the incidence of extra-articular manifestations in patients with RA diagnosed up to 1995. Smoking and early disability are independent risk factors for extra-articular RA.

Full Text

The Full Text of this article is available as a PDF (131.1 KB).

Figure 1.

Figure 1

Open in a new tab

ExRA-free survival in patients with RA by decade of RA diagnosis. ExRA defined according to the Malmö criteria (table 1; criteria 1–8).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allebeck P., Ahlbom A., Allander E. Increased mortality among persons with rheumatoid arthritis, but where RA does not appear on death certificate. Eleven-year follow-up of an epidemiological study. Scand J Rheumatol. 1981;10(4):301–306. doi: 10.3109/03009748109095320. [DOI] [PubMed] [Google Scholar]
  2. Arnett F. C., Edworthy S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., Healey L. A., Kaplan S. R., Liang M. H., Luthra H. S. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988 Mar;31(3):315–324. doi: 10.1002/art.1780310302. [DOI] [PubMed] [Google Scholar]
  3. Bathon J. M., Martin R. W., Fleischmann R. M., Tesser J. R., Schiff M. H., Keystone E. C., Genovese M. C., Wasko M. C., Moreland L. W., Weaver A. L. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med. 2000 Nov 30;343(22):1586–1593. doi: 10.1056/NEJM200011303432201. [DOI] [PubMed] [Google Scholar]
  4. Bergström U., Book C., Lindroth Y., Marsal L., Saxne T., Jacobsson L. Lower disease activity and disability in Swedish patients with rheumatoid arthritis in 1995 compared with 1978. Scand J Rheumatol. 1999;28(3):160–165. doi: 10.1080/03009749950154239. [DOI] [PubMed] [Google Scholar]
  5. Butman S., Espinoza L. R., Del Carpio J., Osterland C. K. Rheumatoid pericarditis. Rapid deterioration with evidence of local vasculitis. JAMA. 1977 Nov 28;238(22):2394–2396. doi: 10.1001/jama.238.22.2394. [DOI] [PubMed] [Google Scholar]
  6. COBB S., ANDERSON F., BAUER W. Length of life and cause of death in rheumatoid arthritis. N Engl J Med. 1953 Oct 1;249(14):553–556. doi: 10.1056/NEJM195310012491402. [DOI] [PubMed] [Google Scholar]
  7. Cimmino M. A., Salvarani C., Macchioni P., Montecucco C., Fossaluzza V., Mascia M. T., Punzi L., Davoli C., Filippini D., Numo R. Extra-articular manifestations in 587 Italian patients with rheumatoid arthritis. Rheumatol Int. 2000;19(6):213–217. doi: 10.1007/pl00006853. [DOI] [PubMed] [Google Scholar]
  8. Combe B., Didry C., Gutierrez M., Anaya J. M., Sany J. Accelerated nodulosis and systemic manifestations during methotrexate therapy for rheumatoid arthritis. Eur J Med. 1993 Mar;2(3):153–156. [PubMed] [Google Scholar]
  9. Doran Michele F., Pond Gregory R., Crowson Cynthia S., O'Fallon W. Michael, Gabriel Sherine E. Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period. Arthritis Rheum. 2002 Mar;46(3):625–631. doi: 10.1002/art.509. [DOI] [PubMed] [Google Scholar]
  10. Enzer Ian, Dunn Graham, Jacobsson Lennart, Bennett Peter H., Knowler William C., Silman Alan. An epidemiologic study of trends in prevalence of rheumatoid factor seropositivity in Pima Indians: evidence of a decline due to both secular and birth-cohort influences. Arthritis Rheum. 2002 Jul;46(7):1729–1734. doi: 10.1002/art.10360. [DOI] [PubMed] [Google Scholar]
  11. Erhardt C. C., Mumford P. A., Venables P. J., Maini R. N. Factors predicting a poor life prognosis in rheumatoid arthritis: an eight year prospective study. Ann Rheum Dis. 1989 Jan;48(1):7–13. doi: 10.1136/ard.48.1.7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Foster C. S., Forstot S. L., Wilson L. A. Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis. Effects of systemic immunosuppression. Ophthalmology. 1984 Oct;91(10):1253–1263. doi: 10.1016/s0161-6420(84)34160-4. [DOI] [PubMed] [Google Scholar]
  13. Gabriel S. E., Crowson C. S., O'Fallon W. M. Mortality in rheumatoid arthritis: have we made an impact in 4 decades? J Rheumatol. 1999 Dec;26(12):2529–2533. [PubMed] [Google Scholar]
  14. Gabriel S. E., Crowson C. S., O'Fallon W. M. The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955-1985. Arthritis Rheum. 1999 Mar;42(3):415–420. doi: 10.1002/1529-0131(199904)42:3<415::AID-ANR4>3.0.CO;2-Z. [DOI] [PubMed] [Google Scholar]
  15. Geirsson A. J., Sturfelt G., Truedsson L. Clinical and serological features of severe vasculitis in rheumatoid arthritis: prognostic implications. Ann Rheum Dis. 1987 Oct;46(10):727–733. doi: 10.1136/ard.46.10.727. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Gordon D. A., Stein J. L., Broder I. The extra-articular features of rheumatoid arthritis. A systematic analysis of 127 cases. Am J Med. 1973 Apr;54(4):445–452. doi: 10.1016/0002-9343(73)90040-5. [DOI] [PubMed] [Google Scholar]
  17. Hara K. S., Ballard D. J., Ilstrup D. M., Connolly D. C., Vollertsen R. S. Rheumatoid pericarditis: clinical features and survival. Medicine (Baltimore) 1990 Mar;69(2):81–91. [PubMed] [Google Scholar]
  18. Harrison B. J., Silman A. J., Wiles N. J., Scott D. G., Symmons D. P. The association of cigarette smoking with disease outcome in patients with early inflammatory polyarthritis. Arthritis Rheum. 2001 Feb;44(2):323–330. doi: 10.1002/1529-0131(200102)44:2<323::AID-ANR49>3.0.CO;2-C. [DOI] [PubMed] [Google Scholar]
  19. Heikkilä S., Isomäki H. Long-term outcome of rheumatoid arthritis has improved. Scand J Rheumatol. 1994;23(1):13–15. doi: 10.3109/03009749409102128. [DOI] [PubMed] [Google Scholar]
  20. Heliövaara M., Aho K., Aromaa A., Knekt P., Reunanen A. Smoking and risk of rheumatoid arthritis. J Rheumatol. 1993 Nov;20(11):1830–1835. [PubMed] [Google Scholar]
  21. Heller R. F., Chinn S., Pedoe H. D., Rose G. How well can we predict coronary heart disease? Findings in the United Kingdom Heart Disease Prevention Project. Br Med J (Clin Res Ed) 1984 May 12;288(6428):1409–1411. doi: 10.1136/bmj.288.6428.1409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Hunder G. G., McDuffie F. C. Hypocomplementemia in rheumatoid arthritis. Am J Med. 1973 Apr;54(4):461–472. doi: 10.1016/0002-9343(73)90042-9. [DOI] [PubMed] [Google Scholar]
  23. Jacobsson L. T., Hanson R. L., Knowler W. C., Pillemer S., Pettitt D. J., McCance D. R., Bennett P. H. Decreasing incidence and prevalence of rheumatoid arthritis in Pima Indians over a twenty-five-year period. Arthritis Rheum. 1994 Aug;37(8):1158–1165. doi: 10.1002/art.1780370808. [DOI] [PubMed] [Google Scholar]
  24. Jacobsson L. T., Knowler W. C., Pillemer S., Hanson R. L., Pettitt D. J., Nelson R. G., del Puente A., McCance D. R., Charles M. A., Bennett P. H. Rheumatoid arthritis and mortality. A longitudinal study in Pima Indians. Arthritis Rheum. 1993 Aug;36(8):1045–1053. doi: 10.1002/art.1780360804. [DOI] [PubMed] [Google Scholar]
  25. Jurik A. G., Graudal H. Pericarditis in rheumatoid arthritis. A clinical and radiological study. Rheumatol Int. 1986;6(1):37–42. doi: 10.1007/BF00270663. [DOI] [PubMed] [Google Scholar]
  26. Kaipiainen-Seppänen O., Aho K., Isomäki H., Laakso M. Incidence of rheumatoid arthritis in Finland during 1980-1990. Ann Rheum Dis. 1996 Sep;55(9):608–611. doi: 10.1136/ard.55.9.608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Karlson E. W., Lee I. M., Cook N. R., Manson J. E., Buring J. E., Hennekens C. H. A retrospective cohort study of cigarette smoking and risk of rheumatoid arthritis in female health professionals. Arthritis Rheum. 1999 May;42(5):910–917. doi: 10.1002/1529-0131(199905)42:5<910::AID-ANR9>3.0.CO;2-D. [DOI] [PubMed] [Google Scholar]
  28. Kurland L. T., Molgaard C. A. The patient record in epidemiology. Sci Am. 1981 Oct;245(4):54–63. doi: 10.1038/scientificamerican1081-54. [DOI] [PubMed] [Google Scholar]
  29. Lipsky P. E., van der Heijde D. M., St Clair E. W., Furst D. E., Breedveld F. C., Kalden J. R., Smolen J. S., Weisman M., Emery P., Feldmann M. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N Engl J Med. 2000 Nov 30;343(22):1594–1602. doi: 10.1056/NEJM200011303432202. [DOI] [PubMed] [Google Scholar]
  30. Martens P. B., Goronzy J. J., Schaid D., Weyand C. M. Expansion of unusual CD4+ T cells in severe rheumatoid arthritis. Arthritis Rheum. 1997 Jun;40(6):1106–1114. doi: 10.1002/art.1780400615. [DOI] [PubMed] [Google Scholar]
  31. Martens P. B., Pillemer S. R., Jacobsson L. T., O'Fallon W. M., Matteson E. L. Survivorship in a population based cohort of patients with Sjögren's syndrome, 1976-1992. J Rheumatol. 1999 Jun;26(6):1296–1300. [PubMed] [Google Scholar]
  32. Masdottir B., Jónsson T., Manfredsdottir V., Víkingsson A., Brekkan A., Valdimarsson H. Smoking, rheumatoid factor isotypes and severity of rheumatoid arthritis. Rheumatology (Oxford) 2000 Nov;39(11):1202–1205. doi: 10.1093/rheumatology/39.11.1202. [DOI] [PubMed] [Google Scholar]
  33. McEntegart A., Capell H. A., Creran D., Rumley A., Woodward M., Lowe G. D. Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis. Rheumatology (Oxford) 2001 Jun;40(6):640–644. doi: 10.1093/rheumatology/40.6.640. [DOI] [PubMed] [Google Scholar]
  34. Melton L. J., 3rd History of the Rochester Epidemiology Project. Mayo Clin Proc. 1996 Mar;71(3):266–274. doi: 10.4065/71.3.266. [DOI] [PubMed] [Google Scholar]
  35. Mitchell D. M., Spitz P. W., Young D. Y., Bloch D. A., McShane D. J., Fries J. F. Survival, prognosis, and causes of death in rheumatoid arthritis. Arthritis Rheum. 1986 Jun;29(6):706–714. doi: 10.1002/art.1780290602. [DOI] [PubMed] [Google Scholar]
  36. Monson R. R., Hall A. P. Mortality among arthritics. J Chronic Dis. 1976 Jul;29(7):459–467. doi: 10.1016/0021-9681(76)90086-2. [DOI] [PubMed] [Google Scholar]
  37. Myllykangas-Luosujärvi R., Aho K., Kautiainen H., Isomäki H. Cardiovascular mortality in women with rheumatoid arthritis. J Rheumatol. 1995 Jun;22(6):1065–1067. [PubMed] [Google Scholar]
  38. Pillemer S. R., Matteson E. L., Jacobsson L. T., Martens P. B., Melton L. J., 3rd, O'Fallon W. M., Fox P. C. Incidence of physician-diagnosed primary Sjögren syndrome in residents of Olmsted County, Minnesota. Mayo Clin Proc. 2001 Jun;76(6):593–599. doi: 10.4065/76.6.593. [DOI] [PubMed] [Google Scholar]
  39. Pincus T., Callahan L. F. Taking mortality in rheumatoid arthritis seriously--predictive markers, socioeconomic status and comorbidity. J Rheumatol. 1986 Oct;13(5):841–845. [PubMed] [Google Scholar]
  40. SOKOLOFF L., MCCLUSKEY R. T., BUNIM J. J. Vascularity of the early subcutaneous nodule of rheumatoid arthritis. AMA Arch Pathol. 1953 Jun;55(6):475–495. [PubMed] [Google Scholar]
  41. Saag K. G., Cerhan J. R., Kolluri S., Ohashi K., Hunninghake G. W., Schwartz D. A. Cigarette smoking and rheumatoid arthritis severity. Ann Rheum Dis. 1997 Aug;56(8):463–469. doi: 10.1136/ard.56.8.463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Sauerbrei W., Schumacher M. A bootstrap resampling procedure for model building: application to the Cox regression model. Stat Med. 1992 Dec;11(16):2093–2109. doi: 10.1002/sim.4780111607. [DOI] [PubMed] [Google Scholar]
  43. Shinton R., Beevers G. Meta-analysis of relation between cigarette smoking and stroke. BMJ. 1989 Mar 25;298(6676):789–794. doi: 10.1136/bmj.298.6676.789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Sibley J. T., Haga M., Visram D. A., Mitchell D. M. The clinical course of Felty's syndrome compared to matched controls. J Rheumatol. 1991 Aug;18(8):1163–1167. [PubMed] [Google Scholar]
  45. Silman A. J. Has the incidence of rheumatoid arthritis declined in the United Kingdom? Br J Rheumatol. 1988 Feb;27(1):77–79. doi: 10.1093/rheumatology/27.1.77. [DOI] [PubMed] [Google Scholar]
  46. Silman A. J., Newman J., MacGregor A. J. Cigarette smoking increases the risk of rheumatoid arthritis. Results from a nationwide study of disease-discordant twins. Arthritis Rheum. 1996 May;39(5):732–735. doi: 10.1002/art.1780390504. [DOI] [PubMed] [Google Scholar]
  47. Struthers G. R., Scott D. L., Delamere J. P., Sheppeard H., Kitt M. Smoking and rheumatoid vasculitis. Rheumatol Int. 1981;1(3):145–146. doi: 10.1007/BF00541260. [DOI] [PubMed] [Google Scholar]
  48. Symmons D., Harrison B. Early inflammatory polyarthritis: results from the norfolk arthritis register with a review of the literature. I. Risk factors for the development of inflammatory polyarthritis and rheumatoid arthritis. Rheumatology (Oxford) 2000 Aug;39(8):835–843. doi: 10.1093/rheumatology/39.8.835. [DOI] [PubMed] [Google Scholar]
  49. Turesson C., Englund P., Jacobsson L. T., Sturfelt G., Truedsson L., Nennesmo I., Lundberg I. E. Increased endothelial expression of HLA-DQ and interleukin 1alpha in extra-articular rheumatoid arthritis. Results from immunohistochemical studies of skeletal muscle. Rheumatology (Oxford) 2001 Dec;40(12):1346–1354. doi: 10.1093/rheumatology/40.12.1346. [DOI] [PubMed] [Google Scholar]
  50. Turesson C., Jacobsson L., Bergström U. Extra-articular rheumatoid arthritis: prevalence and mortality. Rheumatology (Oxford) 1999 Jul;38(7):668–674. doi: 10.1093/rheumatology/38.7.668. [DOI] [PubMed] [Google Scholar]
  51. Turesson C., Jacobsson L., Bergström U., Truedsson L., Sturfelt G. Predictors of extra-articular manifestations in rheumatoid arthritis. Scand J Rheumatol. 2000;29(6):358–364. doi: 10.1080/030097400447552. [DOI] [PubMed] [Google Scholar]
  52. Turesson Carl, O'Fallon W. Michael, Crowson Cynthia S., Gabriel Sherine E., Matteson Eric L. Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis. J Rheumatol. 2002 Jan;29(1):62–67. [PubMed] [Google Scholar]
  53. Vollertsen R. S., Conn D. L., Ballard D. J., Ilstrup D. M., Kazmar R. E., Silverfield J. C. Rheumatoid vasculitis: survival and associated risk factors. Medicine (Baltimore) 1986 Nov;65(6):365–375. [PubMed] [Google Scholar]
  54. Voskuyl A. E., Zwinderman A. H., Westedt M. L., Vandenbroucke J. P., Breedveld F. C., Hazes J. M. Factors associated with the development of vasculitis in rheumatoid arthritis: results of a case-control study. Ann Rheum Dis. 1996 Mar;55(3):190–192. doi: 10.1136/ard.55.3.190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. WILKINSON M., KIRK J. LEG ULCERS COMPLICATING RHEUMATOID ARTHRITIS. Scott Med J. 1965 Apr;10:175–182. doi: 10.1177/003693306501000405. [DOI] [PubMed] [Google Scholar]
  56. Wallberg-Jonsson S., Ohman M. L., Dahlqvist S. R. Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden. J Rheumatol. 1997 Mar;24(3):445–451. [PubMed] [Google Scholar]
  57. Watts R. A., Carruthers D. M., Symmons D. P., Scott D. G. The incidence of rheumatoid vasculitis in the Norwich Health Authority. Br J Rheumatol. 1994 Sep;33(9):832–833. doi: 10.1093/rheumatology/33.9.832. [DOI] [PubMed] [Google Scholar]
  58. Watts R. A., Lane S. E., Bentham G., Scott D. G. Epidemiology of systemic vasculitis: a ten-year study in the United Kingdom. Arthritis Rheum. 2000 Feb;43(2):414–419. doi: 10.1002/1529-0131(200002)43:2<414::AID-ANR23>3.0.CO;2-0. [DOI] [PubMed] [Google Scholar]
  59. Weyand C. M., Xie C., Goronzy J. J. Homozygosity for the HLA-DRB1 allele selects for extraarticular manifestations in rheumatoid arthritis. J Clin Invest. 1992 Jun;89(6):2033–2039. doi: 10.1172/JCI115814. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Wilhelmsen L., Wedel H., Tibblin G. Multivariate analysis of risk factors for coronary heart disease. Circulation. 1973 Nov;48(5):950–958. doi: 10.1161/01.cir.48.5.950. [DOI] [PubMed] [Google Scholar]
  61. Wolfe F., Mitchell D. M., Sibley J. T., Fries J. F., Bloch D. A., Williams C. A., Spitz P. W., Haga M., Kleinheksel S. M., Cathey M. A. The mortality of rheumatoid arthritis. Arthritis Rheum. 1994 Apr;37(4):481–494. doi: 10.1002/art.1780370408. [DOI] [PubMed] [Google Scholar]
  62. Wolfe F. The effect of smoking on clinical, laboratory, and radiographic status in rheumatoid arthritis. J Rheumatol. 2000 Mar;27(3):630–637. [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES